Better adherence to antithyroid drug is associated with decreased risk of stroke in hyperthyroidism patients.

about

Better adherence to antithyroid drug is associated with decreased risk of stroke in hyperthyroidism patients.

Item

http://www.wikidata.org/entity/Q41459329

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Better adherence to antithyroi ...... e in hyperthyroidism patients.

@en

type

Item

label

Better adherence to antithyroi ...... e in hyperthyroidism patients.

@en

prefLabel

Better adherence to antithyroi ...... e in hyperthyroidism patients.

@en

P1476

Better adherence to antithyroi ...... e in hyperthyroidism patients.

@en

P2093

C-H Tang

http://www.w3.org/2001/XMLSchema#string

H-J Cheng

http://www.w3.org/2001/XMLSchema#string

N-C Chen

http://www.w3.org/2001/XMLSchema#string

P-H Yu

http://www.w3.org/2001/XMLSchema#string

P-Y Chuang

http://www.w3.org/2001/XMLSchema#string

W-J Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

Cumulative incidence in competing risks data and competing risks regression analysis.

Thyroid hormone and the cardiovascular system.

Risk factors and biomarkers of ischemic stroke in cancer patients

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.

Hyperthyroidism and the management of atrial fibrillation.

Effects of thyroid hormone on the cardiovascular system.

Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism.

Thyroid diseases and cerebrovascular disease.

P304

1473-1485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJCP.12724

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26299643

http://www.w3.org/2001/XMLSchema#string